ProShare Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Sell |
|
|||||
|
2025
Q1 | $268K | Sell |
|
|||||
|
2024
Q4 | $321K | Buy |
|
|||||
|
2024
Q3 | $336K | Buy |
|
|||||
|
2024
Q2 | $227K | Sell |
|
|||||
|
2024
Q1 | $343K | Buy |
|
|||||
|
2023
Q4 | $263K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $227K | Sell |
|
|||||
|
2021
Q4 | $252K | Buy |
|
|||||
|
2021
Q3 | $257K | Sell |
|
|||||
|
2021
Q2 | $388K | Buy |
|
|||||
|
2021
Q1 | $356K | Buy |
|
|||||
|
2020
Q4 | $259K | Buy |
|
|||||
|
2020
Q3 | $203K | Sell |
|
|||||
|
2020
Q2 | $178K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $239K | Sell |
|
|||||
|
2019
Q3 | $146K | Sell |
|
|||||
|
2019
Q2 | $169K | Sell |
|
|||||
|
2019
Q1 | $220K | Buy |
|
|||||
|
2018
Q4 | $247K | Sell |
|
|||||
|
2018
Q3 | $253K | Sell |
|
|||||
|
2018
Q2 | $423K | Sell |
|
|||||
|
2018
Q1 | $466K | Sell |
|
|||||
|
2017
Q4 | $393K | Buy |
|
|||||
|
2017
Q3 | $191K | Buy |
|
|||||
|
2017
Q2 | $214K | Sell |
|
|||||
|
2017
Q1 | $173K | Sell |
|
|||||
|
2016
Q4 | $335K | Buy |
|
|||||
|
2016
Q3 | $312K | Sell |
|
|||||
|
2016
Q2 | $227K | Buy |
|
|||||
|
2016
Q1 | $332K | Buy |
|
|||||
|
2015
Q4 | $484K | Buy |
|